ID   IFIT2_HUMAN             Reviewed;         472 AA.
AC   P09913; Q5T767;
DT   01-JUL-1989, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1989, sequence version 1.
DT   18-JUN-2025, entry version 208.
DE   RecName: Full=Interferon-induced protein with tetratricopeptide repeats 2;
DE            Short=IFIT-2;
DE   AltName: Full=ISG-54 K;
DE   AltName: Full=Interferon-induced 54 kDa protein;
DE            Short=IFI-54K;
DE            Short=P54;
GN   Name=IFIT2; Synonyms=CIG-42, G10P2, IFI54, ISG54;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3466167; DOI=10.1073/pnas.83.23.8929;
RA   Levy D., Larner A., Chaudhuri A., Babiss L.E., Darnell J.E. Jr.;
RT   "Interferon-stimulated transcription: isolation of an inducible gene and
RT   identification of its regulatory region.";
RL   Proc. Natl. Acad. Sci. U.S.A. 83:8929-8933(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-2.
RX   PubMed=2454816; DOI=10.1111/j.1432-1033.1988.tb14101.x;
RA   Wathelet M.G., Clauss I.M., Content J., Huez G.A.;
RT   "Regulation of two interferon-inducible human genes by interferon,
RT   poly(rI).poly(rC) and viruses.";
RL   Eur. J. Biochem. 174:323-329(1988).
RN   [4]
RP   SIMILARITY TO IFI-56K.
RX   PubMed=3360121; DOI=10.1016/0014-5793(88)80724-5;
RA   Wathelet M.G., Clauss I.M., Content J., Huez G.A.;
RT   "The IFI-56K and IFI-54K interferon-inducible human genes belong to the
RT   same gene family.";
RL   FEBS Lett. 231:164-171(1988).
RN   [5]
RP   INDUCTION, AND INTERACTION WITH EIF3E AND EIF3C.
RX   PubMed=16973618; DOI=10.1074/jbc.m605771200;
RA   Terenzi F., Hui D.J., Merrick W.C., Sen G.C.;
RT   "Distinct induction patterns and functions of two closely related
RT   interferon-inducible human genes, ISG54 and ISG56.";
RL   J. Biol. Chem. 281:34064-34071(2006).
RN   [6]
RP   INTERACTION WITH STING1/MITA.
RX   PubMed=19416887; DOI=10.1073/pnas.0900818106;
RA   Li Y., Li C., Xue P., Zhong B., Mao A.P., Ran Y., Chen H., Wang Y.Y.,
RA   Yang F., Shu H.B.;
RT   "ISG56 is a negative-feedback regulator of virus-triggered signaling and
RT   cellular antiviral response.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:7945-7950(2009).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH IFIT1 AND IFIT3.
RX   PubMed=21190939; DOI=10.1074/jbc.m110.207068;
RA   Stawowczyk M., Van Scoy S., Kumar K.P., Reich N.C.;
RT   "The interferon stimulated gene 54 promotes apoptosis.";
RL   J. Biol. Chem. 286:7257-7266(2011).
RN   [8]
RP   REVIEW.
RX   PubMed=20950130; DOI=10.1089/jir.2010.0101;
RA   Fensterl V., Sen G.C.;
RT   "The ISG56/IFIT1 gene family.";
RL   J. Interferon Cytokine Res. 31:71-78(2011).
RN   [9]
RP   INTERACTION WITH IFIT1 AND IFIT3.
RX   PubMed=21642987; DOI=10.1038/ni.2048;
RA   Pichlmair A., Lassnig C., Eberle C.A., Gorna M.W., Baumann C.L.,
RA   Burkard T.R., Buerckstuemmer T., Stefanovic A., Krieger S., Bennett K.L.,
RA   Ruelicke T., Weber F., Colinge J., Mueller M., Superti-Furga G.;
RT   "IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA.";
RL   Nat. Immunol. 12:624-630(2011).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS), TPR REPEATS, SUBUNIT, AND
RP   MUTAGENESIS OF ARG-184; LYS-255; ARG-259; ARG-292 AND LYS-410.
RX   PubMed=22825553; DOI=10.1038/cr.2012.111;
RA   Yang Z., Liang H., Zhou Q., Li Y., Chen H., Ye W., Chen D., Fleming J.,
RA   Shu H., Liu Y.;
RT   "Crystal structure of ISG54 reveals a novel RNA binding structure and
RT   potential functional mechanisms.";
RL   Cell Res. 22:1328-1338(2012).
CC   -!- FUNCTION: IFN-induced antiviral protein which inhibits expression of
CC       viral messenger RNAs lacking 2'-O-methylation of the 5' cap. The ribose
CC       2'-O-methylation would provide a molecular signature to distinguish
CC       between self and non-self mRNAs by the host during viral infection.
CC       Viruses evolved several ways to evade this restriction system such as
CC       encoding their own 2'-O-methylase for their mRNAs or by stealing host
CC       cap containing the 2'-O-methylation (cap snatching mechanism). Binds
CC       AU-rich viral RNAs, with or without 5' triphosphorylation, RNA-binding
CC       is required for antiviral activity. Can promote apoptosis.
CC       {ECO:0000269|PubMed:21190939}.
CC   -!- SUBUNIT: Domain-swapped homodimer. Component of an interferon-dependent
CC       multiprotein complex, at least composed of IFIT1, IFIT2 and IFIT3.
CC       Interacts with IFIT1 and IFIT3. Interacts with STING1/MITA and disrupts
CC       its interaction with MAVS or TBK1. Interacts with EIF3E and EIF3C.
CC       {ECO:0000269|PubMed:16973618, ECO:0000269|PubMed:19416887,
CC       ECO:0000269|PubMed:21190939, ECO:0000269|PubMed:21642987,
CC       ECO:0000269|PubMed:22825553}.
CC   -!- INTERACTION:
CC       P09913; P09914: IFIT1; NbExp=7; IntAct=EBI-3507167, EBI-745117;
CC       P09913; O14879: IFIT3; NbExp=7; IntAct=EBI-3507167, EBI-745127;
CC       P09913; Q86WV6: STING1; NbExp=3; IntAct=EBI-3507167, EBI-2800345;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:21190939}.
CC       Endoplasmic reticulum {ECO:0000269|PubMed:21190939}.
CC   -!- INDUCTION: By type I interferons, dsRNAs and viruses.
CC       {ECO:0000269|PubMed:16973618}.
CC   -!- DOMAIN: The C-terminal part folds into a super-helical structure and
CC       has an extensively positively-charged nucleotide-binding channel on its
CC       inner surface.
CC   -!- SIMILARITY: Belongs to the IFIT family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M14660; AAA59191.1; -; Genomic_DNA.
DR   EMBL; M14659; AAA59191.1; JOINED; Genomic_DNA.
DR   EMBL; AL353751; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; X07557; CAA30438.1; -; Genomic_DNA.
DR   CCDS; CCDS41548.1; -.
DR   PIR; I59087; I59087.
DR   RefSeq; NP_001538.4; NM_001547.4.
DR   PDB; 4G1T; X-ray; 2.80 A; A/B=1-472.
DR   PDBsum; 4G1T; -.
DR   AlphaFoldDB; P09913; -.
DR   SMR; P09913; -.
DR   BioGRID; 109658; 78.
DR   CORUM; P09913; -.
DR   DIP; DIP-48848N; -.
DR   FunCoup; P09913; 375.
DR   IntAct; P09913; 42.
DR   STRING; 9606.ENSP00000490935; -.
DR   GlyCosmos; P09913; 1 site, 1 glycan.
DR   GlyGen; P09913; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; P09913; -.
DR   PhosphoSitePlus; P09913; -.
DR   BioMuta; IFIT2; -.
DR   DMDM; 124488; -.
DR   jPOST; P09913; -.
DR   MassIVE; P09913; -.
DR   PaxDb; 9606-ENSP00000360891; -.
DR   PeptideAtlas; P09913; -.
DR   ProteomicsDB; 52276; -.
DR   Pumba; P09913; -.
DR   Antibodypedia; 1277; 201 antibodies from 29 providers.
DR   CPTC; P09913; 1 antibody.
DR   DNASU; 3433; -.
DR   Ensembl; ENST00000371826.4; ENSP00000360891.3; ENSG00000119922.11.
DR   Ensembl; ENST00000638108.1; ENSP00000490935.1; ENSG00000119922.11.
DR   Ensembl; ENST00000680809.1; ENSP00000506255.1; ENSG00000119922.11.
DR   Ensembl; ENST00000680954.1; ENSP00000505033.1; ENSG00000119922.11.
DR   GeneID; 3433; -.
DR   KEGG; hsa:3433; -.
DR   MANE-Select; ENST00000371826.4; ENSP00000360891.3; NM_001547.5; NP_001538.4.
DR   UCSC; uc009xts.4; human.
DR   AGR; HGNC:5409; -.
DR   CTD; 3433; -.
DR   DisGeNET; 3433; -.
DR   GeneCards; IFIT2; -.
DR   HGNC; HGNC:5409; IFIT2.
DR   HPA; ENSG00000119922; Tissue enhanced (bone).
DR   MIM; 147040; gene.
DR   OpenTargets; ENSG00000119922; -.
DR   VEuPathDB; HostDB:ENSG00000119922; -.
DR   eggNOG; KOG1124; Eukaryota.
DR   GeneTree; ENSGT00950000182946; -.
DR   HOGENOM; CLU_043482_0_0_1; -.
DR   InParanoid; P09913; -.
DR   OMA; HIGCCYR; -.
DR   OrthoDB; 10043504at2759; -.
DR   PAN-GO; P09913; 3 GO annotations based on evolutionary models.
DR   PhylomeDB; P09913; -.
DR   PathwayCommons; P09913; -.
DR   Reactome; R-HSA-909733; Interferon alpha/beta signaling.
DR   SignaLink; P09913; -.
DR   BioGRID-ORCS; 3433; 14 hits in 1156 CRISPR screens.
DR   ChiTaRS; IFIT2; human.
DR   EvolutionaryTrace; P09913; -.
DR   GeneWiki; IFIT2; -.
DR   GenomeRNAi; 3433; -.
DR   Pharos; P09913; Tbio.
DR   PRO; PR:P09913; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; P09913; protein.
DR   Bgee; ENSG00000119922; Expressed in palpebral conjunctiva and 183 other cell types or tissues.
DR   ExpressionAtlas; P09913; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IBA:GO_Central.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0140374; P:antiviral innate immune response; IDA:UniProt.
DR   GO; GO:0008637; P:apoptotic mitochondrial changes; TAS:UniProtKB.
DR   GO; GO:0051607; P:defense response to virus; IBA:GO_Central.
DR   GO; GO:0032091; P:negative regulation of protein binding; IDA:BHF-UCL.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0009615; P:response to virus; IDA:BHF-UCL.
DR   FunFam; 1.25.40.10:FF:000036; interferon-induced protein with tetratricopeptide repeats 5; 1.
DR   Gene3D; 1.25.40.10; Tetratricopeptide repeat domain; 3.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   InterPro; IPR019734; TPR_rpt.
DR   PANTHER; PTHR10271; INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS; 1.
DR   PANTHER; PTHR10271:SF4; INTERFERON-INDUCED PROTEIN WITH TETRATRICOPEPTIDE REPEATS 2; 1.
DR   Pfam; PF13181; TPR_8; 2.
DR   SMART; SM00028; TPR; 3.
DR   SUPFAM; SSF48452; TPR-like; 2.
DR   PROSITE; PS50005; TPR; 1.
DR   PROSITE; PS50293; TPR_REGION; 1.
DR   neXtProt; NX_P09913; -.
DR   PharmGKB; PA29650; -.
DR   TreeFam; TF342671; -.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Antiviral defense; Apoptosis; Cytoplasm;
KW   Endoplasmic reticulum; Immunity; Innate immunity;
KW   Proteomics identification; Reference proteome; Repeat; RNA-binding;
KW   TPR repeat.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   CHAIN           2..472
FT                   /note="Interferon-induced protein with tetratricopeptide
FT                   repeats 2"
FT                   /id="PRO_0000106347"
FT   REPEAT          51..89
FT                   /note="TPR 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00339,
FT                   ECO:0000269|PubMed:22825553"
FT   REPEAT          90..135
FT                   /note="TPR 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00339,
FT                   ECO:0000269|PubMed:22825553"
FT   REPEAT          136..171
FT                   /note="TPR 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00339,
FT                   ECO:0000269|PubMed:22825553"
FT   REPEAT          172..208
FT                   /note="TPR 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00339,
FT                   ECO:0000269|PubMed:22825553"
FT   REPEAT          247..280
FT                   /note="TPR 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00339,
FT                   ECO:0000269|PubMed:22825553"
FT   REPEAT          281..335
FT                   /note="TPR 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00339,
FT                   ECO:0000269|PubMed:22825553"
FT   REPEAT          336..366
FT                   /note="TPR 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00339,
FT                   ECO:0000269|PubMed:22825553"
FT   REPEAT          367..405
FT                   /note="TPR 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00339,
FT                   ECO:0000269|PubMed:22825553"
FT   REPEAT          406..448
FT                   /note="TPR 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00339,
FT                   ECO:0000269|PubMed:22825553"
FT   REGION          446..472
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        462..472
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0007744|PubMed:22814378"
FT   VARIANT         79
FT                   /note="E -> A (in dbSNP:rs17468739)"
FT                   /id="VAR_052615"
FT   VARIANT         121
FT                   /note="K -> R (in dbSNP:rs2070845)"
FT                   /id="VAR_052616"
FT   VARIANT         352
FT                   /note="D -> E (in dbSNP:rs1727)"
FT                   /id="VAR_014490"
FT   MUTAGEN         184
FT                   /note="R->E: Abolishes RNA-binding."
FT                   /evidence="ECO:0000269|PubMed:22825553"
FT   MUTAGEN         255
FT                   /note="K->E: Significantly impairs RNA-binding; when
FT                   associated with Glu-259."
FT                   /evidence="ECO:0000269|PubMed:22825553"
FT   MUTAGEN         259
FT                   /note="R->E: Significantly impairs RNA-binding; when
FT                   associated with Glu-255."
FT                   /evidence="ECO:0000269|PubMed:22825553"
FT   MUTAGEN         292
FT                   /note="R->E: Abolishes RNA-binding."
FT                   /evidence="ECO:0000269|PubMed:22825553"
FT   MUTAGEN         410
FT                   /note="K->E: Abolishes RNA-binding."
FT                   /evidence="ECO:0000269|PubMed:22825553"
FT   HELIX           9..14
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   TURN            19..21
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   TURN            24..27
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           31..41
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           52..63
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           67..84
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           86..88
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   TURN            90..93
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           94..106
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           110..126
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           136..149
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           153..167
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           172..187
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           195..204
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           209..221
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           231..242
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           247..259
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           263..276
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           281..300
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           309..329
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   TURN            331..333
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           337..346
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           350..362
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           367..383
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           388..400
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           406..425
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           432..445
FT                   /evidence="ECO:0007829|PDB:4G1T"
FT   HELIX           448..451
FT                   /evidence="ECO:0007829|PDB:4G1T"
SQ   SEQUENCE   472 AA;  54632 MW;  3CF11319A5008FB9 CRC64;
     MSENNKNSLE SSLRQLKCHF TWNLMEGENS LDDFEDKVFY RTEFQNREFK ATMCNLLAYL
     KHLKGQNEAA LECLRKAEEL IQQEHADQAE IRSLVTWGNY AWVYYHMGRL SDVQIYVDKV
     KHVCEKFSSP YRIESPELDC EEGWTRLKCG GNQNERAKVC FEKALEKKPK NPEFTSGLAI
     ASYRLDNWPP SQNAIDPLRQ AIRLNPDNQY LKVLLALKLH KMREEGEEEG EGEKLVEEAL
     EKAPGVTDVL RSAAKFYRRK DEPDKAIELL KKALEYIPNN AYLHCQIGCC YRAKVFQVMN
     LRENGMYGKR KLLELIGHAV AHLKKADEAN DNLFRVCSIL ASLHALADQY EDAEYYFQKE
     FSKELTPVAK QLLHLRYGNF QLYQMKCEDK AIHHFIEGVK INQKSREKEK MKDKLQKIAK
     MRLSKNGADS EALHVLAFLQ ELNEKMQQAD EDSERGLESG SLIPSASSWN GE
//
